Periodic Reporting for period 1 - ITHEMYC (Novel immunotherapies for tuberculosis and other mycobacterial diseases)

Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a leading cause of death worldwide. Development of antimicrobial resistance is an important risk during TB treatment, due to the lengthy course of antibiotic therapy and associated adverse events, which can lead...